Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Comparable immunogenicity of VRC DNA and rAD5 AIDS vaccines reported in healthy adults

Nov. 6, 2009

Study in over 4,000 infants reveals immunogenicity of Hib-MenCY-TT vaccine

Nov. 6, 2009

Significant weight loss, diabetes onset delay with liraglutide in obese subjects

Nov. 6, 2009

Lactin-V reduces recurrent urinary tract infection in phase II study

Nov. 6, 2009

SCY-635 shows synergistic antiviral activity in combination with anti-HCV agents in vitro

Nov. 6, 2009

GF-015535-00 shows safety and potent sedative/hypnotic effects in vivo

Nov. 6, 2009

The nAChR agonist WYE-103914 demonstrates efficacy in rodent cognition models

Nov. 6, 2009

Pre-liver transplant therapy with PEG/RBV reduces HCV recurrence

Nov. 5, 2009

Meloxicam is an effective treatment for refractory nocturia in BPH patients

Nov. 5, 2009

Preclinical evaluation of novel nAChR agonist CP-810123 disclosed by Pfizer

Nov. 5, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...